116 related articles for article (PubMed ID: 9067517)
1. Limited efficacy of pentoxifylline as anti-inflammatory agent in experimental pneumococcal meningitis.
Zysk G; Brück W; Fischer FR; Mäder M; Rieckmann P; Nau R
Clin Exp Immunol; 1997 Mar; 107(3):458-61. PubMed ID: 9067517
[TBL] [Abstract][Full Text] [Related]
2. Experimental study of cerebrospinal fluid tumor necrosis factor-alpha release in penicillin- and cephalosporin-resistant pneumococcal meningitis treated with different antibiotic schedules.
Vivas M; Force E; El Haj C; Tubau F; Ariza J; Cabellos C
J Microbiol Immunol Infect; 2017 Aug; 50(4):435-439. PubMed ID: 26452467
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing the anti-inflammatory effect of dexamethasone therapy in experimental pneumococcal meningitis.
Lutsar I; Friedland IR; Jafri HS; Wubbel L; Ahmed A; Trujillo M; McCoig CC; McCracken GH
J Antimicrob Chemother; 2003 Oct; 52(4):651-5. PubMed ID: 12951330
[TBL] [Abstract][Full Text] [Related]
4. Quinupristin/dalfopristin attenuates the inflammatory response and reduces the concentration of neuron-specific enolase in the cerebrospinal fluid of rabbits with experimental Streptococcus pneumoniae meningitis.
Trostdorf F; Reinert RR; Schmidt H; Nichterlein T; Stuertz K; Schmitz-Salue M; Sadowski I; Brück W; Nau R
J Antimicrob Chemother; 1999 Jan; 43(1):87-94. PubMed ID: 10381105
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory treatment influences neuronal apoptotic cell death in the dentate gyrus in experimental pneumococcal meningitis.
Zysk G; Brück W; Gerber J; Brück Y; Prange HW; Nau R
J Neuropathol Exp Neurol; 1996 Jun; 55(6):722-8. PubMed ID: 8642398
[TBL] [Abstract][Full Text] [Related]
6. Trovafloxacin delays the antibiotic-induced inflammatory response in experimental pneumococcal meningitis.
Nau R; Zysk G; Schmidt H; Fischer FR; Stringaris AK; Stuertz K; Brück W
J Antimicrob Chemother; 1997 Jun; 39(6):781-8. PubMed ID: 9222048
[TBL] [Abstract][Full Text] [Related]
7. Effects of polysaccharide fucoidin on cerebrospinal fluid interleukin-1 and tumor necrosis factor alpha in pneumococcal meningitis in the rabbit.
Granert C; Raud J; Waage A; Lindquist L
Infect Immun; 1999 May; 67(5):2071-4. PubMed ID: 10225856
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis.
Leib SL; Clements JM; Lindberg RL; Heimgartner C; Loeffler JM; Pfister LA; Täuber MG; Leppert D
Brain; 2001 Sep; 124(Pt 9):1734-42. PubMed ID: 11522576
[TBL] [Abstract][Full Text] [Related]
9. Activity of fosfomycin in a rabbit model of experimental pneumococcal meningitis.
Nau R; Zysk G; Reinert RR; Mergeryan H; Eiffert H; Prange HW
J Antimicrob Chemother; 1995 Dec; 36(6):997-1004. PubMed ID: 8821598
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide concentrations and cerebrospinal fluid parameters in an experimental animal model of Streptococcus pneumoniae meningitis.
Destache CJ; Pakiz CB; Dash AK; Larsen C
Pharmacotherapy; 1998; 18(3):612-9. PubMed ID: 9620112
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of pentoxifylline as an anti-inflammatory agent in experimental Escherichia coli meningitis in the newborn piglet.
Park WS; Chang YS; Lee M
Biol Neonate; 2000 May; 77(4):236-42. PubMed ID: 10828575
[TBL] [Abstract][Full Text] [Related]
12. Intravenous granulocyte colony-stimulating factor increases the release of tumour necrosis factor and interleukin-1beta into the cerebrospinal fluid, but does not inhibit the growth of Streptococcus pneumoniae in experimental meningitis.
Schmidt H; Stuertz K; Brück W; Chen V; Stringaris AK; Fischer FR; Nau R
Scand J Immunol; 1999 May; 49(5):481-6. PubMed ID: 10320640
[TBL] [Abstract][Full Text] [Related]
13. Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis.
Grandgirard D; Schürch C; Cottagnoud P; Leib SL
Antimicrob Agents Chemother; 2007 Jun; 51(6):2173-8. PubMed ID: 17371820
[TBL] [Abstract][Full Text] [Related]
14. Short-term rifampicin pretreatment reduces inflammation and neuronal cell death in a rabbit model of bacterial meningitis.
Spreer A; Lugert R; Stoltefaut V; Hoecht A; Eiffert H; Nau R
Crit Care Med; 2009 Jul; 37(7):2253-8. PubMed ID: 19487938
[TBL] [Abstract][Full Text] [Related]
15. Rifampin followed by ceftriaxone for experimental meningitis decreases lipoteichoic acid concentrations in cerebrospinal fluid and reduces neuronal damage in comparison to ceftriaxone alone.
Gerber J; Pohl K; Sander V; Bunkowski S; Nau R
Antimicrob Agents Chemother; 2003 Apr; 47(4):1313-7. PubMed ID: 12654664
[TBL] [Abstract][Full Text] [Related]
16. Reduction of meningeal macrophages does not decrease migration of granulocytes into the CSF and brain parenchyma in experimental pneumococcal meningitis.
Trostdorf F; Brück W; Schmitz-Salue M; Stuertz K; Hopkins SJ; van Rooijen N; Huitinga I; Nau R
J Neuroimmunol; 1999 Oct; 99(2):205-10. PubMed ID: 10505976
[TBL] [Abstract][Full Text] [Related]
17. Pentoxifylline modulates meningeal inflammation in experimental bacterial meningitis.
Sáez-Llorens X; Ramilo O; Mustafa MM; Mertsola J; de Alba C; Hansen E; McCracken GH
Antimicrob Agents Chemother; 1990 May; 34(5):837-43. PubMed ID: 2360822
[TBL] [Abstract][Full Text] [Related]
18. Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis.
Fernández A; Cabellos C; Tubau F; Maiques JM; Doménech A; Ribes S; Liñares J; Viladrich PF; Gudiol F
J Antimicrob Chemother; 2005 Jan; 55(1):78-83. PubMed ID: 15546968
[TBL] [Abstract][Full Text] [Related]
19. Nonsteroidal anti-inflammatory agents in the therapy for experimental pneumococcal meningitis.
Tuomanen E; Hengstler B; Rich R; Bray MA; Zak O; Tomasz A
J Infect Dis; 1987 May; 155(5):985-90. PubMed ID: 3470394
[TBL] [Abstract][Full Text] [Related]
20. [The effect of antiinflammatory therapy with dexamethasone and dexamethasone with pentoxifylline on the course of bacterial meningitis].
Bociaga-Jasik M; Kalinowska-Nowak A; Garlicki A; Mach T
Przegl Lek; 2003; 60(11):710-5. PubMed ID: 15058039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
